Clinical Trial Results:
            Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the RPGR gene 
    
|     Summary | |
|     EudraCT number | 2020-002873-88 | 
|     Trial protocol | IE NL BE ES FR DK DE IT Outside EU/EEA | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1 | 
|     This version publication date | 
                                    13 Apr 2025
                             | 
|     First version publication date | 
                                    13 Apr 2025
                             | 
|     Other versions | v2 | 
|     Summary report(s) | Rationale_extension request_ | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
